Cite
PROState Pathway Embedded Comparative Trial: The IP3-PROSPECT study
MLA
B. Khoubehi, et al. “PROState Pathway Embedded Comparative Trial: The IP3-PROSPECT Study.” Contemporary Clinical Trials, vol. 107, Nov. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a5840a1a699c4c7b0b5d7ee6930c87ab&authtype=sso&custid=ns315887.
APA
B. Khoubehi, Thiagarajah Sasikaran, A. Pope, Heminder Sokhi, Hashim U. Ahmed, Tim Dudderidge, Nimalan Arumainayagam, Natalia Klimowska-Nassar, Emily Day, M. Winkler, Matthew R. Sydes, E.J. Bass, & Francesca Fiorentino. (2020). PROState Pathway Embedded Comparative Trial: The IP3-PROSPECT study. Contemporary Clinical Trials, 107.
Chicago
B. Khoubehi, Thiagarajah Sasikaran, A. Pope, Heminder Sokhi, Hashim U. Ahmed, Tim Dudderidge, Nimalan Arumainayagam, et al. 2020. “PROState Pathway Embedded Comparative Trial: The IP3-PROSPECT Study.” Contemporary Clinical Trials 107 (November). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a5840a1a699c4c7b0b5d7ee6930c87ab&authtype=sso&custid=ns315887.